GLP-1 side effects

GLP-1 receptor agonists such as semaglutide and liraglutide, used for diabetes and weight management, most commonly cause gastrointestinal side effects including nausea, vomiting, diarrhoea, and constipation. Most side effects are mild to moderate and settle as the body adjusts, particularly if the dose is increased gradually. Less commonly, they can cause gallstones, pancreatitis, or injection site reactions.

GLP-1 drugs work partly by slowing stomach emptying and reducing appetite, and this same mechanism is what causes nausea and digestive symptoms in many users. Side effects tend to be most noticeable when starting the medication or after a dose increase. They usually settle over one to two weeks as the gut adapts.

Nausea is the most frequently reported side effect, followed by vomiting, diarrhoea, constipation, and reduced appetite. Some people also notice fatigue, heartburn, or a metallic taste. Eating smaller, lower-fat meals and avoiding lying down straight after eating can help reduce symptoms.

Most side effects are unpleasant rather than dangerous and improve with time or dose adjustment. However, severe abdominal pain radiating to the back can signal pancreatitis, and this needs urgent medical assessment. Persistent vomiting leading to dehydration, or signs of gallbladder problems such as right-sided abdominal pain, should also be reviewed promptly.

Gastrointestinal side effects are usually most intense in the first few weeks of treatment or after each dose increase, then settle as the body adjusts. Some mild nausea can persist at higher doses for as long as the medication is continued. If side effects remain severe beyond a few weeks, your prescriber may slow the dose escalation or adjust treatment.

Starting at a low dose and increasing gradually, as most prescribing schedules recommend, is the main way to reduce side effects. Eating smaller meals, avoiding very fatty or rich food, staying hydrated, and eating slowly can also help. Anti-nausea medication is occasionally used short-term if symptoms are troublesome.

Seek urgent care for severe, persistent abdominal pain, especially if it radiates to the back, as this can indicate pancreatitis. Also seek medical advice for signs of dehydration, yellowing of the skin or eyes, or an allergic reaction such as facial swelling or difficulty breathing. For milder but persistent symptoms, a routine review with your prescriber is appropriate.

Mild nausea, slightly reduced appetite, and occasional loose stools in the first few weeks are typical and expected as the body adjusts. Warning signs that go beyond normal adjustment include severe unrelenting abdominal pain, persistent vomiting preventing you from keeping fluids down, or dark urine and jaundice. If you are unsure whether what you are experiencing is normal, it is always reasonable to check with your prescribing clinician.

No, side effects are not a sign of ineffectiveness; in fact, many people who experience appetite-related side effects go on to have good weight or blood sugar responses. Some people tolerate GLP-1 medication with minimal side effects and still respond well. Response to treatment is assessed through weight, blood sugar, or other clinical markers rather than through side effects.

Book a review if side effects are affecting your ability to eat, drink, or function normally after the first few weeks on a stable dose. A GP or the prescribing weight-management or diabetes service can usually review dosing within about two weeks privately, compared with potentially longer waits through routine NHS follow-up. Do not stop a prescribed GLP-1 medication abruptly without discussing it with your prescriber first.